Expression of Lmo2 accelerates the onset of leukemia in Tal1 transgenic mice, and LMO1/LMO2 are commonly expressed in human TAL1-driven T-ALL [156,157]. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.